Rates of 14C-2-deoxy glucose uptake were determined in (a) ingWAT, (b) pgWAT, (c) skeletal muscle (SkM), and (d) iBAT after a retro-orbital injection of tracer with one of three treatments: vehicle, 0.75 mU/kg insulin, or 0.1 μg/g body weight of the β3-adrinergic agonist mirabegron (β3-ARA). n=5–6 per group. *P < 0.05, **P < 0.01 vs. vehicle.